全文获取类型
收费全文 | 535020篇 |
免费 | 20414篇 |
国内免费 | 957篇 |
专业分类
耳鼻咽喉 | 7444篇 |
儿科学 | 17979篇 |
妇产科学 | 13525篇 |
基础医学 | 74727篇 |
口腔科学 | 15097篇 |
临床医学 | 39499篇 |
内科学 | 108613篇 |
皮肤病学 | 13643篇 |
神经病学 | 42019篇 |
特种医学 | 20388篇 |
外国民族医学 | 199篇 |
外科学 | 70883篇 |
综合类 | 2539篇 |
一般理论 | 83篇 |
预防医学 | 50084篇 |
眼科学 | 12148篇 |
药学 | 38487篇 |
2篇 | |
中国医学 | 1318篇 |
肿瘤学 | 27714篇 |
出版年
2021年 | 5329篇 |
2020年 | 3223篇 |
2019年 | 5912篇 |
2018年 | 14090篇 |
2017年 | 10641篇 |
2016年 | 10001篇 |
2015年 | 11822篇 |
2014年 | 11852篇 |
2013年 | 16232篇 |
2012年 | 31397篇 |
2011年 | 27657篇 |
2010年 | 13470篇 |
2009年 | 11839篇 |
2008年 | 21485篇 |
2007年 | 23489篇 |
2006年 | 22444篇 |
2005年 | 29751篇 |
2004年 | 29990篇 |
2003年 | 24520篇 |
2002年 | 19125篇 |
2001年 | 14008篇 |
2000年 | 12197篇 |
1999年 | 14089篇 |
1998年 | 2007篇 |
1992年 | 11386篇 |
1991年 | 11113篇 |
1990年 | 11282篇 |
1989年 | 10484篇 |
1988年 | 9812篇 |
1987年 | 9283篇 |
1986年 | 8987篇 |
1985年 | 8087篇 |
1984年 | 5728篇 |
1983年 | 4733篇 |
1982年 | 2054篇 |
1979年 | 5929篇 |
1978年 | 3795篇 |
1977年 | 3198篇 |
1976年 | 2782篇 |
1975年 | 3966篇 |
1974年 | 4970篇 |
1973年 | 4673篇 |
1972年 | 4555篇 |
1971年 | 4490篇 |
1970年 | 4200篇 |
1969年 | 4204篇 |
1968年 | 3905篇 |
1967年 | 3616篇 |
1966年 | 3194篇 |
1965年 | 2000篇 |
排序方式: 共有10000条查询结果,搜索用时 875 毫秒
61.
62.
63.
64.
Torbj?rn Karlsson 《Upsala journal of medical sciences》2015,120(4):257-262
Background. Haemophagocytic lymphohistiocytosis (HLH) is a rare clinical syndrome characterized by fever, hepatosplenomegaly, cytopenia, and progressive multiple-organ failure. HLH in adults is often secondary to autoimmune diseases, cancer, or infections in contrast to familial HLH. Treatment of secondary HLH is directed against the triggering disease in addition to immunosuppressive therapy, the latter commonly according to the HLH-2004 protocol.Methods. We conducted a retrospective study to identify triggering diseases, disease-specific and immunosuppressive therapy administered, and prognosis in adult patients with secondary HLH. Patient data were collected from October 2010 to January 2015.Results. Ten adult patients with secondary HLH were identified. Seven were men, and the median age at diagnosis was 62 years. Five cases were triggered by malignant disease and five by infection. The median patient fulfilled five of the eight HLH-2004 diagnostic criteria. All patients fulfilled the criteria fever, cytopenia, and ferritin >500 µg/L. Median time from hospital admission to HLH diagnosis was 20 days. Four patients received immunosuppressive therapy according to the HLH-2004 protocol. The prognosis was dismal, especially for the patients with malignancy-associated HLH, of whom all died.Conclusion. HLH should be suspected in patients who present with fever, cytopenia, and ferritin >500 µg/L. Secondary HLH has a dismal prognosis. None of the patients with HLH triggered by malignancy survived. Achieving remission of the triggering disease seems to be important for a favourable outcome as, in all surviving patients, the haemophagocytic syndrome resolved after remission of the underlying infection. 相似文献
65.
Spontaneous generation of functional osteoclasts from synovial fluid mononuclear cells as a model of inflammatory osteoclastogenesis
下载免费PDF全文
![点击此处可从《APMIS : acta pathologica, microbiologica, et immunologica Scandinavica》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Stinne R. Greisen Halldór Bjarki Einarsson Malene Hvid Ellen‐Margrethe Hauge Bent Deleuran Tue Wenzel Kragstrup 《APMIS : acta pathologica, microbiologica, et immunologica Scandinavica》2015,123(9):779-786
In osteoimmunology, osteoclastogenesis is understood in the context of the immune system. Today, the in vitro model for osteoclastogenesis necessitates the addition of recombinant human receptor activator of nuclear factor kappa‐B ligand (RANKL) and macrophage colony‐stimulating factor (M‐CSF). The peripheral joints of patients with rheumatoid arthritis (RA) and spondyloarthritis (SpA) are characterized by an immune‐mediated inflammation that can lead to bone destruction. Here, we evaluate spontaneous in vitro osteoclastogenesis in cultures of synovial fluid mononuclear cells (SFMCs) activated only in vivo. SFMCs were isolated and cultured for 21 days at 0.5–1.0 × 106 cells/mL in culture medium. SFMCs and healthy control peripheral blood monocytes were cultured with RANKL and M‐CSF as controls. Tartrate‐resistant acid phosphatase (TRAP) positive multinucleated cells were found in the SFMC cultures after 21 days. These cells expressed the osteoclast genes calcitonin receptor, cathepsin K, and integrin β3, formed lacunae on dentin plates and secreted matrix metalloproteinase 9 (MMP9) and TRAP. Adding RANKL and M‐CSF potentiated this secretion. In conclusion, we show that SFMCs from inflamed peripheral joints can spontaneously develop into functionally active osteoclasts ex vivo. Our study provides a simple in vitro model for studying inflammatory osteoclastogenesis. 相似文献
66.
67.
68.
69.
Annals of Nuclear Medicine - Cardiac amyloidosis is a rare disease characterized by amyloid heart deposits and is usually a part of systemic amyloidosis, in relation to systemic light chain (AL)... 相似文献
70.
Dominique Trudel Luminita-Mihaela Avarvarei Michèle Orain Stéphane Turcotte Marie Plante Jean Grégoire Reinhild Kappelhoff David P. Labbé Dimcho Bachvarov Bernard Têtu Christopher M. Overall Isabelle Bairati 《Pathology, research and practice》2019,215(6):152369
Ovarian carcinoma is one of the most lethal malignancies, but only very few prognostic biomarkers are known. The degradome, comprising proteases, protease non-proteolytic homologues and inhibitors, have been involved in the prognosis of many cancer types, including ovarian carcinoma. The prognostic significance of the whole degradome family has not been specifically studied in high-grade serous ovarian cancer. A targeted DNA microarray known as the CLIP-CHIP microarray was used to identify potential prognostic factors in ten high-grade serous ovarian cancer women who had early recurrence (<1.6 years) or late/no recurrence after first line surgery and chemotherapy. In women with early recurrence, we identified seven upregulated genes (TMPRSS4, MASP1/3, SPC18, PSMB1, IGFBP2, CFI – encoding Complement Factor I – and MMP9) and one down-regulated gene (ADAM-10). Using immunohistochemistry, we evaluated the prognostic effect of these 8 candidate genes in an independent cohort of 112 high-grade serous ovarian cancer women. Outcomes were progression, defined according to CA-125 criteria, and death. Multivariate Cox proportional hazard regression models were done to estimate the associations between each protein and each outcome. High ADAM-10 expression (intensity of 2–3) was associated with a lower risk of progression (adjusted hazard ratio (HR): 0.51; 95% confidence interval (CI): 0.29-0.87). High complement factor I expression (intensity 2–3) was associated with a higher risk of progression (adjusted HR: 2.30, 95% CI: 1.17–4.53) and death (adjusted HR: 3.42; 95% CI: 1.72–6.79). Overall, we identified the prognostic value of two proteases, ADAM-10 and complement factor I, for high-grade serous ovarian cancer which could have clinical significance. 相似文献